Nanfang Hospital
Nanfang Hospital
Guangzhou, Guangdong, China16 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 3 | 2026-07-30 | NCT04194775 | |
| HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Active, not recruiting | Phase 2 / Phase 3 | 2026-05-18 | NCT05535933 | |
| A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding. | Gastric Variceal | Recruiting | Not applicable | 2026-04-16 | NCT07532915 | |
| A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, systemic lupus erythematosus | Recruiting | Phase 1 | 2026-02-02 | NCT07331272 | |
| The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System. | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, glomerulonephritis, kidney disorder, kidney failure, nephritis, urinary system disorder | Recruiting | Not stated | 2026-01-27 | NCT07330362 | |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-12-16 | NCT07189065 | |
| A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-11-17 | NCT06258408 | |
| A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2025-08-12 | NCT05667506 | |
| Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-08-08 | NCT04684147 | |
| ICP-332 in Subjects With Non-segmental Vitiligo | Non Segmental Vitiligo | Recruiting | Phase 2 / Phase 3 | 2025-08-07 | NCT07047612 | |
| AI-Driven Cancer Diagnosis and Prediction With EHR | neoplasm | Recruiting | Not stated | 2025-07-30 | NCT06791473 | |
| AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data | AI Agent | Recruiting | Not stated | 2025-04-17 | NCT06791499 | |
| AI-Driven Prediction of Biological Age With EHR | Biological Age | Recruiting | Not stated | 2025-04-02 | NCT06791486 | |
| Long-term Efficacy and Safety Study of GV-971 | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 4 | 2024-11-15 | NCT05181475 | |
| Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Not stated | 2024-10-15 | NCT06039696 | |
| Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, gastroesophageal junction adenocarcinoma, neoplasm, stomach disorder | Recruiting | Phase 2 | 2023-12-14 | NCT06155383 |